The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Strategies to overcome barriers to accrual (BtA) to NCI-sponsored clinical trials: A project of the NCI-Myeloma Steering Committee Accrual Working Group (NCI-MYSC AWG).
Matthias Weiss
No relevant relationships to disclose
Morie A. Gertz
No relevant relationships to disclose
Richard F. Little
No relevant relationships to disclose
Vincent Rajkumar
No relevant relationships to disclose
Susanna J. Jacobus
No relevant relationships to disclose
Rafat Abonour
No relevant relationships to disclose
Kenneth Carl Anderson
No relevant relationships to disclose
Bart Barlogie
No relevant relationships to disclose
Natalie Scott Callander
No relevant relationships to disclose
Edward J. Gorak
No relevant relationships to disclose
Jeffrey Matous
No relevant relationships to disclose
Glenn Morris Mills
No relevant relationships to disclose
Robert C. Kane
No relevant relationships to disclose
Michael S. Katz
No relevant relationships to disclose
LeeAnn Jensen
No relevant relationships to disclose
James Omel
No relevant relationships to disclose
Robert Z. Orlowski
No relevant relationships to disclose
Paul Gerard Guy Richardson
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Johnson & Johnson; Millennium; Novartis
Nikhil C. Munshi
No relevant relationships to disclose